[Significance of lipiodol-CT in the evaluation of therapeutic effects of Lp-TAE for hepatocellular carcinoma--clinicopathologic study].
Jinno
K
K
Tokuyama
K
K
Yumoto
Y
Y
Wada
T
T
Okamoto
T
T
Kobashi
H
H
Moriwaki
S
S
Tanada
M
M
Maeda
H
H
Konno
T
T
D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D007459:Iodized Oil / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D008299:Maleic Anhydrides / Q000008:administration & dosage; D008875:Middle Aged; D011137:Polystyrenes / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed; D009353:Zinostatin / Q000008:administration & dosage / Q000031:analogs & derivatives
D008299:Maleic Anhydrides; D011137:Polystyrenes; C035755:poly(maleic acid-styrene)neocarzinostatin; D007459:Iodized Oil; D009353:Zinostatin